NY S00760

Amends a 2024 law requiring health insurance coverage for epinephrine auto-injector devices used to treat life-threatening allergic reactions

Removes the requirement that insurers cover "at a minimum, two" devices, changing language to simply require coverage for "medically necessary" epinephrine auto-injectors

Limits applicability to health plans that provide both major medical coverage and prescription drug coverage

Maintains the $100 annual out-of-pocket cap for covered individuals regardless of deductibles, copayments, or coinsurance

Clarifies that for Health Savings Account-qualified high deductible plans, coverage may be subject to the plan's annual deductible to preserve HSA eligibility under federal tax law (26 USC 223)